Mark Erlander

Mark Erlander

Chief Executive Officer presso CARDIFF ONCOLOGY, INC.

Patrimonio netto: 130 729 $ in data 31/03/2024

64 anni
Consumer Services
Health Technology
Health Services

Profilo

Mark Erlander is currently the Chief Executive Officer & Director at Cardiff Oncology, Inc. He previously held positions as the Chief Scientific Officer at Biotheranostics, Inc., Assistant Professor at The Scripps Research Institute, Chief Scientific Officer at Gensignia Life Sciences, Inc., and Chief Scientific Officer at Arcturus Studios Holdings, Inc. He also worked as a Principal at Johnson & Johnson.
Dr. Erlander holds a doctorate degree from the University of California, Los Angeles, a graduate degree from Iowa State University, and an undergraduate degree from the University of California, Davis.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
07/03/2024 24 481 ( 0.05% ) 130 729 $ 31/03/2024

Posizioni attive di Mark Erlander

SocietàPosizioneInizio
CARDIFF ONCOLOGY, INC. Chief Executive Officer 08/05/2020
Tutte le posizioni attive di Mark Erlander

Precedenti posizioni note di Mark Erlander

SocietàPosizioneFine
Chief Tech/Sci/R&D Officer 01/03/2014
Chief Tech/Sci/R&D Officer 01/02/2013
Chief Tech/Sci/R&D Officer 01/01/2008
JOHNSON & JOHNSON Corporate Officer/Principal 01/01/2000
Corporate Officer/Principal 01/01/1994
Vedi nel dettaglio l'esperienza di Mark Erlander

Formazione di Mark Erlander

University of California, Los Angeles Doctorate Degree
Iowa State University Graduate Degree
University of California, Davis Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark Erlander

Relazioni

100 +

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
JOHNSON & JOHNSON

Health Technology

CARDIFF ONCOLOGY, INC.

Health Technology

Aziende private3

Health Services

Health Technology

Technology Services

Vedi le connessioni aziendali